CD40LG and COVID-19: The antibody levels in nonsurvivors were significantly lower than those in survivors (P = 0.01 and P = 0.06 for IgM and IgG, respectively, two-sided Wilcoxon rank-sum test, Supplementary Fig. 4), suggesting that the antibody response played important roles in helping the severe/critical COVID-19 patients recover.